Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Atenolol-induced pseudolymphoma.

C A Henderson¹, H K Shamy

¹Department of Dermatology, York District Hospital, UK.

Clinical and Experimental Dermatology

|March 1, 1990

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Environmental and Edaphic Factors that Influence Spring Dead Spot Epidemics.

Phytopathology·2023

Same author

The use of haploidy to develop plants that express several recessive traits using light-seeded canola (Brassica napus) as an example.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013

Same author

The association between gastro-oesophageal reflux disease and asthma: a systematic review.

Gut·2007

Same author

Suppurative panniculitis associated with alpha 1-antitrypsin deficiency (PiSZ phenotype) treated with doxycycline.

The British journal of dermatology·2001

Same author

Papuloerythroderma of Ofuji responding to treatment with cyclosporin.

Clinical and experimental dermatology·2000

Same author

Sebum excretion rates in mothers and neonates.

The British journal of dermatology·2000

Same journal

The evolving understanding of prurigo nodularis.

Clinical and experimental dermatology·2026

Same journal

Cutaneous inflammatory biomarkers in rosacea and their association with disease severity.

Clinical and experimental dermatology·2026

Same journal

A slowly enlarging pink nodular lesion with arborizing vessels on the scalp.

Clinical and experimental dermatology·2026

Same journal

Guselkumab for checkpoint inhibitor-exacerbated psoriasis in a patient with metastatic melanoma.

Clinical and experimental dermatology·2026

Same journal

Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort.

Clinical and experimental dermatology·2026

Same journal

A second case of recessive mosaicism in ABCA12 causing a congenital unilateral epidermal nevus.

Clinical and experimental dermatology·2026

See all related articles

Pseudolymphoma syndrome is a reversible condition causing fever, swollen lymph nodes, and rash. This case highlights atenolol as a potential drug trigger, expanding the list of implicated medications beyond anticonvulsants.

Area of Science:

Pharmacology
Immunology
Dermatology

Background:

Pseudolymphoma syndrome is a rare, reversible condition characterized by fever, lymphadenopathy, and rash.
Historically, anticonvulsant medications have been the primary drugs implicated in pseudolymphoma syndrome.
The spectrum of causative agents is expanding, necessitating broader clinical awareness.

Observation:

This report details a specific case of pseudolymphoma syndrome.
The patient presented with symptoms consistent with the syndrome.
The condition was found to be associated with the use of atenolol.

Findings:

Atenolol, a beta-blocker, is identified as a potential causative agent in pseudolymphoma syndrome.
This finding expands the known iatrogenic causes of pseudolymphoma syndrome.

Related Experiment Videos

The syndrome's reversibility upon drug withdrawal is a key characteristic.

Implications:

Clinicians should consider atenolol and other non-anticonvulsant drugs when diagnosing pseudolymphoma syndrome.
Early recognition and drug withdrawal are crucial for managing this reversible condition.
Further research may elucidate the precise immunological mechanisms underlying drug-induced pseudolymphoma.